Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,256.00    0.00 (0.00%)
Bid:
1,248.00
Ask:
1,282.00
Spread: 34.00 (2.724%)
Market Cap: £575.57m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

EBT Purchase

6 Aug 2020 13:10

RNS Number : 3991V
Cohort PLC
06 August 2020
 

6 August 2020

COHORT PLC ("Cohort")

COHORT PLC (the "Company")

EBT Purchase

The Company was notified on 3 August 2020 by the trustees of the Cohort Employee Benefit Trust ("EBT") that they purchased 13,368 ordinary shares of 10 pence each in the Company on 31 July 2020 at a price of 593.78 pence per share. The shares held in the EBT are intended to be used to satisfy awards made under the Cohort employee share schemes.

The EBT is a discretionary trust for the benefit of employees of Cohort plc and its subsidiaries. The Executive Directors of Cohort plc are included in the class of beneficiaries of the EBT and are deemed to be interested in those shares and the dealings thereof.

Following this transaction, a total of 224,416 ordinary shares, representing 0.55 per cent of the Company's total voting rights, are held in the EBT.

Ends

For further information, please contact:

Cohort plc

0118 909 0390

Andrew Thomis, Chief ExecutiveSimon Walther, Finance Director

Investec Bank plc

020 7597 5970

Daniel Adams

Chris Baird

MHP Communications Limited

020 3128 8100

Peter Lambie / Reg Hoare / Alice McLaren

 

 

 

 

NOTES TO EDITORS

Cohort plc (www.cohortplc.com) is the parent company of five innovative, agile and responsive businesses based in the UK and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.

Chess Technologies, through its operating businesses Chess Dynamics and Vision4ce, offers systems and technologies for detecting, tracking, classifying and disrupting naval, land and air threats. It was acquired by Cohort plc in December 2018. www.chess-dynamics.com & www.vision4ce.com

EID designs and manufactures advanced communications systems for the defence and security markets. Cohort acquired a majority stake in June 2016. www.eid.pt

MASS is a specialist defence and technology business, focused on electronic warfare, information systems and cyber security. Acquired by Cohort in August 2006. www.mass.co.uk

MCL - an expert in sourcing, design and integration of communications and surveillance technology, as well as support and training for UK end users including the MOD and other government agencies. MCL has been part of the Group since July 2014. www.marlboroughcomms.com

SEA is an advanced electronic systems and software house operating in the defence, transport and offshore energy markets. Acquired by Cohort in October 2007. www.sea.co.uk

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Reading, Berkshire and employs in total around 950 core staff there and at its other operating company sites across the UK and in Portugal.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCKKABKBBKDAFK
Date   Source Headline
14th Mar 20225:11 pmRNSDirector/PDMR Shareholding
7th Mar 20224:36 pmRNSPrice Monitoring Extension
28th Feb 20223:32 pmRNSHolding(s) in Company
28th Feb 20222:55 pmRNSTotal Voting Rights
25th Feb 202212:15 pmRNSBlock listing Interim Review
23rd Feb 20227:00 amRNSSEA AWARDED CONTRACT TO SUPPLY TORPEDO SYSTEM
17th Feb 202212:05 pmRNSDirector/PDMR Shareholding
2nd Feb 20224:20 pmRNSEBT purchase of shares
31st Jan 20225:30 pmRNSDirector/PDMR Shareholding
31st Jan 20224:00 pmRNSTotal Voting Rights
31st Jan 20222:15 pmRNSEBT Purchase
25th Jan 20224:40 pmRNSSecond Price Monitoring Extn
25th Jan 20224:35 pmRNSPrice Monitoring Extension
25th Jan 20224:35 pmRNSDirector/PDMR Shareholding
24th Jan 20224:42 pmRNSSecond Price Monitoring Extn
24th Jan 20224:37 pmRNSPrice Monitoring Extension
19th Jan 20224:41 pmRNSSecond Price Monitoring Extn
19th Jan 20224:35 pmRNSPrice Monitoring Extension
18th Jan 20227:00 amRNSInterim Report 2021
11th Jan 20226:21 pmRNSDirector/PDMR Shareholding
15th Dec 20214:41 pmRNSSecond Price Monitoring Extn
15th Dec 20214:35 pmRNSPrice Monitoring Extension
14th Dec 20215:30 pmRNSDirector/PDMR Shareholding
14th Dec 20217:00 amRNSHalf Year Results
30th Nov 20214:24 pmRNSTotal Voting Rights
18th Nov 20217:00 amRNSEID Awarded Dismounted Soldier System Contract
29th Oct 20215:00 pmRNSTotal Voting Rights
15th Oct 20215:00 pmRNSDirector/PDMR Shareholding
13th Oct 20212:00 pmRNSDirector/PDMR Shareholding
5th Oct 20215:52 pmRNSDirector/PDMR Shareholding
5th Oct 20215:48 pmRNSBlock Listing Application
5th Oct 20215:41 pmRNSReplacement: Block listing Interim Review
5th Oct 20215:15 pmRNSHolding(s) in Company
5th Oct 202110:20 amRNSBlock listing Interim Review
30th Sep 20214:40 pmRNSSecond Price Monitoring Extn
30th Sep 20214:35 pmRNSPrice Monitoring Extension
30th Sep 20214:21 pmRNSTotal Voting Rights
20th Sep 20214:10 pmRNSResult of AGM
20th Sep 20217:00 amRNSAGM Statement & First Quarter Update
17th Sep 20214:27 pmRNSBlock listing Interim Review
9th Sep 20217:00 amRNSMass awarded £11m contract extension
26th Aug 20217:00 amRNSAnnual Report and Notice of Annual General Meeting
20th Aug 20212:22 pmRNSPDMR Shareholdings
20th Aug 20217:00 amRNSSEA wins £4.6m upgrade contract for overseas navy
18th Aug 20219:56 amRNSEBT Purchase
12th Aug 202112:50 pmRNSEBT Purchase
10th Aug 20215:00 pmRNSDirector Share Awards and Shareholdings
10th Aug 202110:51 amRNSEBT Purchase - Replacement
10th Aug 202110:50 amRNSEBT Purchase - Replacement
6th Aug 202111:51 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.